After 2016s foreign takeover spree. We have the world covered on daybreak asia. We go to watch the developments out of beijing as chinese mostators watch the prolific overseas dealmakers. And we are watching the e. U. Summit in brussels throughout the morning through this is daybreak asia, coming to you sive from bloomberg asian headquarters. I am yvonne man. Betty is that the wharton global conference. A very busy friday and a happy one as well. Yvonne we are marking the oneyear anniversary of brexit. We have the stress test, keeping an eye out on china as well. First it was anbang, but regulators could be targeting other companies. A lot of big guests on our show with betty. Starting this hour, Geoffrey Garrett in 40 minutes time. On Bloomberg Markets, betty will be speaking to the incoming chief executive of hong kong. Her as have to talk to we start next week, marking the anniversary of the handover. You do not want to miss bettys chat with tom friedman at 10 40 a. M. Hongyou do no
Redwood Investment Management LLC bought a new position in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 20,458 shares of the medical research company’s stock, valued at approximately $4,650,000. Other institutional investors […]
Fortrea (NASDAQ:FTRE – Get Free Report) and Laboratory Co. of America (NYSE:LH – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Insider & Institutional Ownership 95.9% of Laboratory […]
Morningstar Investment Management LLC bought a new stake in Laboratory Co. of America Holdings (NYSE:LH – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,146 shares of the medical research company’s stock, valued at approximately $260,000. […]